West Pharmaceutical Services competitorsClear all

West Pharmaceutical Services's top competitors include Loxo Oncology, Keryx Biopharmaceuticals, Chiasma and Fate Therapeutics.
West Pharmaceutical Services
West Pharmaceutical Services
West Pharmaceutical Services manufactures and sells packaging components and delivery systems for injectable drugs and healthcare products internationally.
Loxo Oncology
Loxo Oncology
Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.
Keryx Biopharmaceuticals
Keryx Biopharmaceuticals
Keryx Biopharmaceuticals is a biopharmaceutical company focused on the development of products for the treatment of renal diseases.
Chiasma
Chiasma
Chiasma is a biopharmaceutical company focused on improving the lives of patients who face challenges associated with existing treatments for their rare and serious chronic diseases.
Fate Therapeutics
Fate Therapeutics
Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.
Founding Date
Founding Date
1923
Founding Date
2013
Founding Date
1998
Founding Date
2001
Founding Date
2007
Type
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Exton, US HQ
Locations
Stamford, US HQ
South San Francisco, US
Locations
New York, US HQ
Boston, US
Locations
Waltham, US HQ
Ness Ziona, IL
Locations
San Diego, US HQ
Employees
Employees
7,7003% increase
Employees
5926% increase
Employees
N/A
Employees
1813% increase
Employees
10430% increase
Valuation ($)
Valuation ($)
8.8 b
Valuation ($)
7.2 b
Valuation ($)
N/A
Valuation ($)
251.3 m
Valuation ($)
1.1 b
Twitter followers
Twitter followers
2.1 k
Twitter followers
46
Twitter followers
395
Twitter followers
50
Twitter followers
853
Alexa Website Rank
Alexa Website Rank
339694
Alexa Website Rank
780594
Alexa Website Rank
435952
Alexa Website Rank
1359490
Alexa Website Rank
588476

Financial

Revenue (est.)
Revenue (est.)
$1.5b (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
$60.6m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
$143.6m (FY, 2016)
Net income
($148.9m) (FY, 2017)
Net income
($163.4m) (FY, 2017)
Net income
($31.3m) (FY, 2018)
Net income
($66.6m) (FY, 2018)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 57m
Total funding raised
N/A
Total funding raised
$ 139.8m
Total funding raised
$ 157.2m
For sources of this data, please see the company profile

View company profiles

Loxo Oncology
HQ
Stamford, US
Employees
59↑ 26% increase

Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.

View company
Keryx Biopharmaceuticals
HQ
New York, US

Keryx Biopharmaceuticals is a biopharmaceutical company focused on the development of products for the treatment of renal diseases.

View company
Chiasma
HQ
Waltham, US
Employees
18↑ 13% increase

Chiasma is a biopharmaceutical company focused on improving the lives of patients who face challenges associated with existing treatments for their rare and serious chronic diseases.

View company
Fate Therapeutics
HQ
San Diego, US
Employees
104↑ 30% increase

Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.

View company